# Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.

> **NCT01250782** · PHASE2 · UNKNOWN · sponsor: **Hospital Universitari Son Dureta** · enrollment: 150 (estimated)

## Conditions studied

- Trauma ICU Patients

## Interventions

- **DRUG:** Glutamine
- **DRUG:** Physiological serum

## Key facts

- **NCT ID:** NCT01250782
- **Lead sponsor:** Hospital Universitari Son Dureta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250782, "Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01250782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*